{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:47:37Z","timestamp":1790930857527,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.08.058","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T08:27:11Z","timestamp":1255768031000},"page":"D40-D43","source":"Crossref","is-referenced-by-count":76,"special_numbering":"S4","title":["Brucellosis: The case for live, attenuated vaccines"],"prefix":"10.1016","volume":"27","author":[{"given":"Thomas A.","family":"Ficht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Kahl-McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Arenas-Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison C.","family":"Rice-Ficht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2009.08.058_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.058_bib2","unstructured":"Alausa O.K., Corbel M.J., Elberg S.S., Gargani G., Gubina E.A., Shi-Lang L., et al., AT Joint FAO\/WHO expert committee on brucellosis, World Health Organization Technical Report Series, 740, January, 1986, 1\u2013132"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.08.058_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"June (22)","key":"10.1016\/j.vaccine.2009.08.058_bib4","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","volume":"352","author":"Pappas","year":"2005","journal-title":"N Engl J Med"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.08.058_bib5","first-page":"909","article-title":"Successful therapeutic regimens for treating Brucella melitensis and Brucella abortus infections in cows","volume":"12","author":"Radwan","year":"1993","journal-title":"Rev\u2014Off Int Epizoot"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.08.058_bib6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2460\/ajvr.1989.50.07.1004","article-title":"Efficacy of various treatment regimens, using liposomal streptomycin in cows with brucellosis","volume":"50","author":"Nicoletti","year":"1989","journal-title":"Am J Vet Res"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.08.058_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2460\/javma.1985.187.05.493","article-title":"Efficacy of long-acting oxytetracycline alone or combined with streptomycin in the treatment of bovine brucellosis","volume":"187","author":"Nicoletti","year":"1985","journal-title":"J Am Vet Med Assoc"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.08.058_bib8","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2460\/ajvr.1984.45.09.1825","article-title":"Effectiveness of various therapeutic regimens for bovine brucellosis","volume":"45","author":"Milward","year":"1984","journal-title":"Am J Vet Res"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.08.058_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2460\/javma.1983.183.01.70","article-title":"Effect of oxytetracycline administration on antibody response to Brucella abortus vaccination in calves","volume":"183","author":"Smith","year":"1983","journal-title":"J Am Vet Med Assoc"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2009.08.058_bib10","first-page":"231","article-title":"Oxytetracycline treatment of cows with long-standing brucellosis","volume":"7","author":"Fensterbank","year":"1976","journal-title":"Ann Rech Vet"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.08.058_bib11","first-page":"389","article-title":"Contribution to the antibiotic therapy of Brucella abortus","volume":"107","author":"Gutschmidt","year":"1968","journal-title":"Therapie der Gegenwart"},{"issue":"January","key":"10.1016\/j.vaccine.2009.08.058_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-0711-5-24","article-title":"In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics","volume":"5","author":"Turkmani","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.08.058_bib13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/13543784.15.10.1141","article-title":"Future trends in human brucellosis treatment","volume":"15","author":"Pappas","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.08.058_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1592\/phco.2006.26.1.3","article-title":"Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents","volume":"26","author":"Brouillard","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"October (6)","key":"10.1016\/j.vaccine.2009.08.058_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000088960","article-title":"Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains","volume":"51","author":"Al Dahouk","year":"2005","journal-title":"Chemotherapy"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2009.08.058_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijantimicag.2004.05.003","article-title":"Treatment of Brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen","volume":"24","author":"Pappas","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.08.058_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jac\/dkl257","article-title":"Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin","volume":"58","author":"Lec\u00e1roz","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2009.08.058_bib18","first-page":"85","article-title":"The use of live vaccine for vaccination of human beings against brucellosis in the USSR","volume":"24","author":"Vershilova","year":"1961","journal-title":"Bull World Health Organ"},{"issue":"December (1\u20134)","key":"10.1016\/j.vaccine.2009.08.058_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0378-1135(02)00233-X","article-title":"Brucella vaccines in wildlife","volume":"90","author":"Davis","year":"2002","journal-title":"Vet Microbiol"},{"issue":"December (1\u20134)","key":"10.1016\/j.vaccine.2009.08.058_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"issue":"July","key":"10.1016\/j.vaccine.2009.08.058_bib21","article-title":"Protection of mice from Brucella infection by immunization with attenuated Salmonellaenterica serovar typhimurium expressing A L7\/L12 and BLS fusion antigen of Brucella","author":"Zhao","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.08.058_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2009.08.058_bib23","first-page":"12","article-title":"Immunogencity of HSA-L7\/L12 (Brucella abortus ribosomal protein) in an animal model","volume":"6","author":"Pakzad","year":"2009","journal-title":"Iran J Immunol"},{"issue":"January","key":"10.1016\/j.vaccine.2009.08.058_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-8518-7-1","article-title":"Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella","volume":"7","author":"Harms","year":"2009","journal-title":"Journal of immune based therapies and vaccines"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.08.058_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.imbio.2008.07.004","article-title":"Cloning, expression and immunogenicity of the translation initiation factor 3 homologue of Brucella abortus","volume":"214","author":"Gonz\u00e1lez","year":"2009","journal-title":"Immunobiology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.08.058_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/dna.2008.0790","article-title":"A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle","volume":"28","author":"Hu","year":"2009","journal-title":"DNA Cell Biol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.08.058_bib27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4315\/0362-028X-71.10.2001","article-title":"Elimination of Listeria monocytogenes from vacuum-packed dry-cured ham by E-beam radiation","volume":"71","author":"Hoz","year":"2008","journal-title":"J Food Protect"},{"issue":"September (7)","key":"10.1016\/j.vaccine.2009.08.058_bib28","doi-asserted-by":"crossref","first-page":"M280","DOI":"10.1111\/j.1750-3841.2007.00451.x","article-title":"Inactivation kinetics of Escherichia coli by pulsed electron beam","volume":"72","author":"Chalise","year":"2007","journal-title":"J Food Sci"},{"issue":"10","key":"10.1016\/j.vaccine.2009.08.058_bib29","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1128\/IAI.00451-07","article-title":"Aerosol infection of BALB\/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge","volume":"75","author":"Kahl-McDonagh","year":"2007","journal-title":"Infect Immun"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.08.058_bib30","first-page":"E15","article-title":"Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis","volume":"9","author":"Bossi","year":"2004","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2009.08.058_bib31","first-page":"421","article-title":"Immunization against Brucella infection: VIII. The response of Cynomolgus philippinensis. Guinea pigs and pregnant goats to infection by the Rev-1 strain of Brucella melitensis","volume":"26","author":"Elberg","year":"1962","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2009.08.058_bib32","first-page":"667","article-title":"Studies of vaccination during calfhood to prevent bovine infectious abortion","volume":"41","author":"Buck","year":"1930","journal-title":"J Agric Res"},{"issue":"3","key":"10.1016\/j.vaccine.2009.08.058_bib33","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/IAI.66.3.1008-1016.1998","article-title":"Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival","volume":"66","author":"Allen","year":"1998","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.08.058_bib34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1128\/IAI.68.3.1297-1303.2000","article-title":"Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis","volume":"68","author":"Foulongne","year":"2000","journal-title":"Infect Immun"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.08.058_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1462-5822.2001.00131.x","article-title":"Identification of Brucella spp. genes involved in intracellular trafficking","volume":"3","author":"Delrue","year":"2001","journal-title":"Cell Microbiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.08.058_bib36","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/IAI.71.6.3020-3027.2003","article-title":"Isolation and characterization of mini-Tn5Km2 insertion mutants of Brucella abortus deficient in internalization and intracellular growth in HeLa cells","volume":"71","author":"Kim","year":"2003","journal-title":"Infect Immun"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.08.058_bib37","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1128\/IAI.71.12.7053-7060.2003","article-title":"Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice","volume":"71","author":"Lestrate","year":"2003","journal-title":"Infect Immun"},{"issue":"November (24)","key":"10.1016\/j.vaccine.2009.08.058_bib38","doi-asserted-by":"crossref","first-page":"15711","DOI":"10.1073\/pnas.232454299","article-title":"The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell","volume":"99","author":"Kohler","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (3\u20134)","key":"10.1016\/j.vaccine.2009.08.058_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vetmic.2008.05.003","article-title":"Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2","volume":"132","author":"Fiorentino","year":"2008","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.08.058_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1135(00)00225-X","article-title":"Attenuation and immunogenicity of a Brucella abortus htrA cycL double mutant in cattle","volume":"76","author":"Edmonds","year":"2000","journal-title":"Vet Microbiol"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2009.08.058_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"van der Lubben","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2009.08.058_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.imlet.2005.11.006","article-title":"Differential macrophage modulation of asymmetric IgG antibody synthesis by soluble or particulate stimuli","volume":"103","author":"Apicella","year":"2006","journal-title":"Immunol Lett"},{"issue":"December (48\u201349)","key":"10.1016\/j.vaccine.2009.08.058_bib43","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1016\/j.vaccine.2005.06.031","article-title":"Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target","volume":"23","author":"Manocha","year":"2005","journal-title":"Vaccine"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2009.08.058_bib44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejpb.2006.11.028","article-title":"Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis","volume":"66","author":"Zhu","year":"2007","journal-title":"European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft f\u00fcr Pharmazeutische Verfahrenstechnik eV"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.08.058_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vaccine.2008.10.065","article-title":"Efficacy of bp26 and bp26\/omp31 B. melitensis Rev. 1 deletion mutants against Brucella ovis in rams","volume":"27","author":"Grill\u00f3","year":"2009","journal-title":"Vaccine"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2009.08.058_bib46","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.vaccine.2009.01.025","article-title":"Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep","volume":"27","author":"Barrio","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.08.058_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/IAI.00379-07","article-title":"Cytotoxicity in macrophages infected with rough Brucella mutants is type IV secretion system dependent","volume":"76","author":"Pei","year":"2008","journal-title":"Infect Immun"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2009.08.058_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1574-695X.2008.00441.x","article-title":"VirB type IV secretory system does not contribute to Brucella suis avoidance of human dendritic cell maturation","volume":"53","author":"Billard","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"Feburary (2)","key":"10.1016\/j.vaccine.2009.08.058_bib49","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/IAI.01244-06","article-title":"Characterization of the urease operon of Brucella abortus and assessment of its role in virulence of the bacterium","volume":"75","author":"Sangari","year":"2007","journal-title":"Infect Immun"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2009.08.058_bib50","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1462-5822.2006.00749.x","article-title":"The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB","volume":"8","author":"Dozot","year":"2006","journal-title":"Cell Microbiol"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2009.08.058_bib51","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1016\/j.vaccine.2006.04.005","article-title":"Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis","volume":"24","author":"Kahl-McDonagh","year":"2006","journal-title":"Vaccine"},{"issue":"December (1\u20134)","key":"10.1016\/j.vaccine.2009.08.058_bib52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0378-1135(02)00226-2","article-title":"Characterization of the caprine model for ruminant brucellosis","volume":"90","author":"Elzer","year":"2002","journal-title":"Vet Microbiol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.08.058_bib53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2460\/ajvr.2004.65.644","article-title":"Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta)","volume":"65","author":"Mense","year":"2004","journal-title":"Am J Vet Res"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.08.058_bib54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/infdis\/134.3.294","article-title":"Priming of Macaca cynomolgus philippinensis with purified antigen of Brucella melitensis before injection of Rev. I vaccine","volume":"134","author":"Chen","year":"1976","journal-title":"J Infect Dis"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2009.08.058_bib55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0021-9975(73)90060-1","article-title":"Immunization against Brucella infections. Priming of Cynomolgus philipinensis with purified antigen of Brucella melitensis prior to injection of Rev. I vaccine","volume":"83","author":"Chen","year":"1973","journal-title":"J Comp Pathol"},{"issue":"December (1\u20134)","key":"10.1016\/j.vaccine.2009.08.058_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1135(02)00240-7","article-title":"The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United States","volume":"90","author":"Ragan","year":"2002","journal-title":"Vet Microbiol"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2009.08.058_bib57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/infdis\/154.5.915","article-title":"Laboratory-acquired meningitis caused by Brucella abortus strain 19","volume":"154","author":"Montes","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.058_bib58","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.1954.73690290003006a","article-title":"Human sickness caused by Brucella abortus, Strain 19","volume":"155","author":"Bardenwerper","year":"1954","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.08.058_bib59","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2460\/ajvr.1985.46.04.902","article-title":"Characterization of Brucella abortus Strain 19 isolated from human and bovine tissues and fluids","volume":"46","author":"Meyer","year":"1985","journal-title":"Am J Vet Res"},{"issue":"September (13)","key":"10.1016\/j.vaccine.2009.08.058_bib60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/vr.93.13.380","article-title":"Letter: Contracting brucellosis from S19 vaccine","volume":"93","author":"Andrew","year":"1973","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2009.08.058_bib61","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0264-410X(90)90247-J","article-title":"Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice","volume":"8","author":"Bosseray","year":"1990","journal-title":"Vaccine"},{"issue":"June 1","key":"10.1016\/j.vaccine.2009.08.058_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1135(02)00016-0","article-title":"Brucella abortus INTA2, a novel strain 19 (Delta)bp26::luc (Delta)bmp18 double mutant lacking drug resistance markers","volume":"87","author":"Campos","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.058_bib63","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/IAI.62.8.3206-3212.1994","article-title":"Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308","volume":"62","author":"Stevens","year":"1994","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.08.058_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0378-1135(96)84554-8","article-title":"In vitro and in vivo phenotypes resulting from deletion of the high temperature requirement A (htrA) gene from the bovine vaccine strain Brucella abortus S19","volume":"49","author":"Robertson","year":"1996","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.08.058_bib65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11250-008-9228-0","article-title":"Seroprevalence of brucellosis in yaks (Poephagus grunniens) in India and evaluation of protective immunity to S19 vaccine","volume":"41","author":"Bandyopadhyay","year":"2009","journal-title":"Trop Anim Health Prod"},{"key":"10.1016\/j.vaccine.2009.08.058_bib66","first-page":"83","article-title":"The results of eleven years\u2019 vaccinating with Strain 19","volume":"63","author":"Stuart","year":"1959","journal-title":"Proc Annu Meet US Livestock Sanit Assoc"},{"key":"10.1016\/j.vaccine.2009.08.058_bib67","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/vr.62.52.823","article-title":"Strain 19 and the control of brucellosis","volume":"62","author":"Lawson","year":"1950","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2009.08.058_bib68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0007-1935(17)43705-5","article-title":"Brucella abortus infection in the horse","volume":"117","author":"Millar","year":"1961","journal-title":"Br Vet J"},{"key":"10.1016\/j.vaccine.2009.08.058_bib69","first-page":"29","article-title":"Results of reindeer vaccination with Brucella abortus strain 19","volume":"41","author":"Golosov","year":"1964","journal-title":"Veterinariia"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.058_bib70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0264-410X(84)90004-5","article-title":"Vaccination of cattle with Brucella abortus strain 19 administered by differing routes and doses","volume":"2","author":"Nicoletti","year":"1984","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2009.08.058_bib71","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2460\/ajvr.1983.44.09.1641","article-title":"Protection by oral administration of Brucella abortus strain 19 against an oral challenge exposure with a pathogenic strain of Brucella","volume":"44","author":"Nicoletti","year":"1983","journal-title":"Am J Vet Res"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.058_bib72","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2460\/ajvr.1998.59.08.1016","article-title":"Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence","volume":"59","author":"Lord","year":"1998","journal-title":"Am J Vet Res"},{"issue":"11","key":"10.1016\/j.vaccine.2009.08.058_bib73","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2460\/ajvr.1991.52.11.1848","article-title":"Effect of stage of gestation on efficacy of Brucella abortus strain-19 vaccination in cattle","volume":"52","author":"Crawford","year":"1991","journal-title":"Am J Vet Res"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2009.08.058_bib74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2460\/javma.1991.199.07.887","article-title":"Effects of stage of gestation and breed on bovine responses to vaccination with Brucella abortus strain 19","volume":"199","author":"Crawford","year":"1991","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.058_bib75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7589\/0090-3558-27.2.258","article-title":"Brucella abortus in Bison. II. Evaluation of strain 19 vaccination of pregnant cows","volume":"27","author":"Davis","year":"1991","journal-title":"J Wildl Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.058_bib76","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00402559","article-title":"Isolation of Brucella abortus from experimentally infected dromedary camels in Sudan: a preliminary report","volume":"13","author":"Abu Damir","year":"1989","journal-title":"Vet Res Commun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.058_bib77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/01652176.1983.9693879","article-title":"The serological response of adult cattle to vaccination with reduced dose Brucella abortus S19, a trial under Zambian conditions","volume":"5","author":"Schuurman","year":"1983","journal-title":"Vet Q"},{"issue":"8","key":"10.1016\/j.vaccine.2009.08.058_bib78","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1128\/IAI.66.8.3862-3866.1998","article-title":"Vector development for the expression of foreign proteins in the vaccine strain Brucella abortus S19","volume":"66","author":"Comerci","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.058_bib79","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/IAI.65.2.798-800.1997","article-title":"Protection against infection in mice vaccinated with a Brucella abortus mutant","volume":"65","author":"Boschiroli","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.058_bib80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1749-6632.2002.tb04359.x","article-title":"Evaluation of Brucella abortus strain RB51 and strain 19 in pronghorn antelope","volume":"969","author":"Elzer","year":"2002","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2009.08.058_bib81","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.01017-08","article-title":"The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle","volume":"77","author":"Arenas-Gamboa","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.058_bib82","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jama.1953.02940300020006","article-title":"Human brucellosis caused by Brucella abortus, strain 19","volume":"153","author":"Spink","year":"1953","journal-title":"JAMA"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2009.08.058_bib83","doi-asserted-by":"crossref","first-page":"e2193","DOI":"10.1371\/journal.pone.0002193","article-title":"Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes","volume":"3","author":"Crasta","year":"2008","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2009.08.058_bib84","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1128\/IAI.01787-05","article-title":"Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB\/c mice","volume":"74","author":"Kahl-McDonagh","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.058_bib85","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2460\/ajvr.1996.57.05.677","article-title":"Protection of BALB\/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4","volume":"57","author":"Winter","year":"1996","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2009.08.058_bib86","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.71.6.3261-3271.2003","article-title":"Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model","volume":"71","author":"Monreal","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.058_bib87","first-page":"409","article-title":"Immunization with live Brucella organisms: results of safety test in humans","volume":"26","author":"Spink","year":"1962","journal-title":"Bull WHO"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T20:26:07Z","timestamp":1739391967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09012158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":87,"alternative-id":["S0264410X09012158"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}